CDK4/6 Inhibitors: Game Changers in the Management of Hormone Receptor –Positive Advanced Breast Cancer?

Here, we review the current use of and potential next directions for CDK4/6 inhibitors in the treatment of patients with HR-positive breast cancer.

Source: CancerNetwork - May 15, 2018 Category: Cancer & Oncology Authors: Maria Raquel Nunes, MD Mirat Shah, MD Vered Stearns, MD Tags: Breast Cancer Oncology Journal Review Article Source Type: news